US Stock MarketDetailed Quotes

RSLS ReShape Lifesciences

Watchlist
  • 4.3800
  • -0.0900-2.01%
Close Dec 20 16:00 ET
  • 4.3800
  • 0.00000.00%
Post 20:01 ET
3.12MMarket Cap-0.44P/E (TTM)

ReShape Lifesciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
88.81%-311K
79.63%-1.36M
59.06%-2.07M
22.56%-16.96M
13.15%-2.46M
47.28%-2.78M
-3.74%-6.66M
31.40%-5.06M
-42.45%-21.9M
17.43%-2.83M
Net income from continuing operations
55.26%-1.58M
54.34%-1.6M
17.62%-2.19M
75.36%-11.39M
89.69%-1.7M
71.00%-3.53M
63.01%-3.49M
67.20%-2.66M
26.81%-46.21M
55.09%-16.47M
Operating gains losses
93.20%-28K
15.81%-426K
99.29%-21K
-839.32%-3.91M
-119.18%-28K
-20,700.00%-412K
---506K
---2.97M
-89.15%529K
--146K
Depreciation and amortization
-90.00%5K
-87.76%6K
-87.50%6K
-92.85%154K
-98.64%7K
-90.79%50K
-91.01%49K
-91.27%48K
9.23%2.15M
-7.21%515K
Deferred tax
-150.00%-1K
--0
200.00%1K
106.62%28K
149.09%27K
100.54%2K
--0
---1K
-70.56%-423K
77.82%-55K
Other non cash items
--0
-88.89%1K
-99.67%1K
173.91%17K
-14,550.00%-293K
--0
350.00%9K
1,605.00%301K
-103.67%-23K
-111.76%-2K
Change In working capital
560.09%1M
108.30%258K
1,065.96%454K
-683.07%-4.13M
-174.53%-761K
80.16%-218K
-321.53%-3.11M
92.37%-47K
126.14%709K
197.67%1.02M
-Change in receivables
60.37%-191K
-82.05%7K
1,995.24%440K
-81.56%125K
2,504.76%547K
-359.14%-482K
-57.61%39K
-94.46%21K
338.73%678K
-96.59%21K
-Change in inventory
812.90%283K
-61.90%64K
196.30%320K
60.83%-465K
-693.85%-772K
-11.43%31K
160.22%168K
110.07%108K
-221.68%-1.19M
133.33%130K
-Change in prepaid assets
-37.59%88K
174.29%78K
87.12%-47K
-115.07%-172K
-64.72%157K
-58.89%141K
-121.43%-105K
-166.42%-365K
1,601.32%1.14M
37.77%445K
-Change in payables and accrued expense
1,092.75%823K
103.43%109K
-175.29%-259K
-871.65%-3.46M
-238.88%-693K
104.45%69K
-352.14%-3.18M
43.33%344K
135.00%448K
-10.57%499K
-Change in other current liabilities
--0
--0
--0
50.94%-182K
--0
95.54%-5K
79.38%-33K
-476.00%-144K
47.23%-371K
79.21%-74K
-Change in other working capital
----
----
----
--17K
--0
--28K
--0
---11K
----
----
Cash from discontinued investing activities
Operating cash flow
88.81%-311K
79.63%-1.36M
59.06%-2.07M
22.56%-16.96M
13.15%-2.46M
47.28%-2.78M
-3.74%-6.66M
31.40%-5.06M
-42.45%-21.9M
17.43%-2.83M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
89.13%-10K
0
0
-116.67%-3K
-450.00%-7K
-104.96%-92K
97.42%-79K
Capital expenditure reported
--0
--0
--0
67.18%-43K
--0
--0
-200.00%-36K
0.00%-7K
62.78%-131K
-17.91%-79K
Net PPE purchase and sale
--0
----
----
-15.38%33K
--0
--0
----
----
--39K
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
89.13%-10K
--0
--0
-116.67%-3K
-450.00%-7K
-104.96%-92K
97.42%-79K
Financing cash flow
Cash flow from continuing financing activities
0
-98.93%24K
0
461.47%17.57M
755.96%5.46M
-11,366.67%-338K
-9.60%2.25M
10.2M
-90.60%3.13M
638K
Net common stock issuance
----
----
--0
----
----
----
----
--10.2M
----
----
Proceeds from stock option exercised by employees
--0
----
----
66.04%4.14M
413,700.00%4.14M
-415,133.33%-12.45M
----
----
-94.59%2.49M
---1K
Net other financing activities
----
----
----
2,002.97%13.44M
--13.78M
----
----
----
119.76%639K
----
Cash from discontinued financing activities
Financing cash flow
--0
-98.93%24K
--0
461.47%17.57M
755.96%5.46M
-11,366.67%-338K
-9.60%2.25M
--10.2M
-90.60%3.13M
--638K
Net cash flow
Beginning cash position
-75.29%1.15M
-72.71%2.48M
15.27%4.56M
-82.66%3.96M
-75.20%1.55M
-59.57%4.67M
-41.25%9.08M
-82.66%3.96M
658.73%22.82M
-78.68%6.25M
Current changes in cash
90.03%-311K
69.81%-1.33M
-140.37%-2.07M
103.20%604K
232.33%3M
41.20%-3.12M
-12.77%-4.42M
169.59%5.13M
-195.37%-18.86M
65.04%-2.27M
Effect of exchange rate changes
--1K
800.00%7K
-60.00%-8K
--0
130.00%6K
--0
0.00%-1K
-123.81%-5K
-86.21%4K
-233.33%-20K
End cash Position
-45.58%843K
-75.29%1.15M
-72.71%2.48M
15.27%4.56M
15.27%4.56M
-75.20%1.55M
-59.57%4.67M
-41.25%9.08M
-82.66%3.96M
-82.66%3.96M
Free cash flow
88.81%-311K
79.74%-1.36M
59.12%-2.07M
22.83%-17M
15.51%-2.46M
47.61%-2.78M
-4.10%-6.7M
31.37%-5.07M
-40.10%-22.03M
16.75%-2.91M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 88.81%-311K79.63%-1.36M59.06%-2.07M22.56%-16.96M13.15%-2.46M47.28%-2.78M-3.74%-6.66M31.40%-5.06M-42.45%-21.9M17.43%-2.83M
Net income from continuing operations 55.26%-1.58M54.34%-1.6M17.62%-2.19M75.36%-11.39M89.69%-1.7M71.00%-3.53M63.01%-3.49M67.20%-2.66M26.81%-46.21M55.09%-16.47M
Operating gains losses 93.20%-28K15.81%-426K99.29%-21K-839.32%-3.91M-119.18%-28K-20,700.00%-412K---506K---2.97M-89.15%529K--146K
Depreciation and amortization -90.00%5K-87.76%6K-87.50%6K-92.85%154K-98.64%7K-90.79%50K-91.01%49K-91.27%48K9.23%2.15M-7.21%515K
Deferred tax -150.00%-1K--0200.00%1K106.62%28K149.09%27K100.54%2K--0---1K-70.56%-423K77.82%-55K
Other non cash items --0-88.89%1K-99.67%1K173.91%17K-14,550.00%-293K--0350.00%9K1,605.00%301K-103.67%-23K-111.76%-2K
Change In working capital 560.09%1M108.30%258K1,065.96%454K-683.07%-4.13M-174.53%-761K80.16%-218K-321.53%-3.11M92.37%-47K126.14%709K197.67%1.02M
-Change in receivables 60.37%-191K-82.05%7K1,995.24%440K-81.56%125K2,504.76%547K-359.14%-482K-57.61%39K-94.46%21K338.73%678K-96.59%21K
-Change in inventory 812.90%283K-61.90%64K196.30%320K60.83%-465K-693.85%-772K-11.43%31K160.22%168K110.07%108K-221.68%-1.19M133.33%130K
-Change in prepaid assets -37.59%88K174.29%78K87.12%-47K-115.07%-172K-64.72%157K-58.89%141K-121.43%-105K-166.42%-365K1,601.32%1.14M37.77%445K
-Change in payables and accrued expense 1,092.75%823K103.43%109K-175.29%-259K-871.65%-3.46M-238.88%-693K104.45%69K-352.14%-3.18M43.33%344K135.00%448K-10.57%499K
-Change in other current liabilities --0--0--050.94%-182K--095.54%-5K79.38%-33K-476.00%-144K47.23%-371K79.21%-74K
-Change in other working capital --------------17K--0--28K--0---11K--------
Cash from discontinued investing activities
Operating cash flow 88.81%-311K79.63%-1.36M59.06%-2.07M22.56%-16.96M13.15%-2.46M47.28%-2.78M-3.74%-6.66M31.40%-5.06M-42.45%-21.9M17.43%-2.83M
Investing cash flow
Cash flow from continuing investing activities 00089.13%-10K00-116.67%-3K-450.00%-7K-104.96%-92K97.42%-79K
Capital expenditure reported --0--0--067.18%-43K--0--0-200.00%-36K0.00%-7K62.78%-131K-17.91%-79K
Net PPE purchase and sale --0---------15.38%33K--0--0----------39K--0
Cash from discontinued investing activities
Investing cash flow --0--0--089.13%-10K--0--0-116.67%-3K-450.00%-7K-104.96%-92K97.42%-79K
Financing cash flow
Cash flow from continuing financing activities 0-98.93%24K0461.47%17.57M755.96%5.46M-11,366.67%-338K-9.60%2.25M10.2M-90.60%3.13M638K
Net common stock issuance ----------0------------------10.2M--------
Proceeds from stock option exercised by employees --0--------66.04%4.14M413,700.00%4.14M-415,133.33%-12.45M---------94.59%2.49M---1K
Net other financing activities ------------2,002.97%13.44M--13.78M------------119.76%639K----
Cash from discontinued financing activities
Financing cash flow --0-98.93%24K--0461.47%17.57M755.96%5.46M-11,366.67%-338K-9.60%2.25M--10.2M-90.60%3.13M--638K
Net cash flow
Beginning cash position -75.29%1.15M-72.71%2.48M15.27%4.56M-82.66%3.96M-75.20%1.55M-59.57%4.67M-41.25%9.08M-82.66%3.96M658.73%22.82M-78.68%6.25M
Current changes in cash 90.03%-311K69.81%-1.33M-140.37%-2.07M103.20%604K232.33%3M41.20%-3.12M-12.77%-4.42M169.59%5.13M-195.37%-18.86M65.04%-2.27M
Effect of exchange rate changes --1K800.00%7K-60.00%-8K--0130.00%6K--00.00%-1K-123.81%-5K-86.21%4K-233.33%-20K
End cash Position -45.58%843K-75.29%1.15M-72.71%2.48M15.27%4.56M15.27%4.56M-75.20%1.55M-59.57%4.67M-41.25%9.08M-82.66%3.96M-82.66%3.96M
Free cash flow 88.81%-311K79.74%-1.36M59.12%-2.07M22.83%-17M15.51%-2.46M47.61%-2.78M-4.10%-6.7M31.37%-5.07M-40.10%-22.03M16.75%-2.91M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Alphabet-C
GOOG
+1.72%

Unlock the Full List